RareCyte—a Seattle-based life sciences and precision diagnostics company specializing in advanced single-cell analysis and liquid biopsy platforms—is led by Joe Victor, who serves as the President and Chief Executive Officer. He guides the firm's strategic technological developments, commercial partnerships, and research applications supporting translational oncology and clinical laboratories.